Back to search

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

Data up to Jan 2025

Published1991
Citations86
References18

Total Citations Per Year

Abstract

References (18)

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

1985 • 1,817 citations

Immunoblotting and dot immunobinding — Current status and outlook

1984 • 979 citations

The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells

1985 • 712 citations

A multivariate analysis of prognostic factors in early stage hodgkin's disease

1985 • 144 citations

Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease

1987 • 116 citations

Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

1990 • 103 citations

Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T‐cell leukemia and infectious mononucleosis

1990 • 53 citations

Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma

1991 • 51 citations

Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome

1989 • 45 citations

Prognostic risk factors in advanced Hodgkin's lymphoma

1988 • 45 citations

Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.

1988 • 42 citations

High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease.

1989 • 42 citations

Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.

1988 • 38 citations

Serum levels of soluble CD30 molecule (Ki‐1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

1990 • 23 citations

Immunoscintigraphy of Hodgkin's disease: In vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines

1990 • 21 citations

Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome

1989 • 4 citations

Cited By (0)

Loading...
Clinical significance of soluble CD30 antigen in the sera of patients with untreated… (1991) – Blood | Metascience Observatory Explorer